Page last updated: 2024-08-22

tricalcium phosphate and su 11248

tricalcium phosphate has been researched along with su 11248 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, L; Huo, M; Satterlee, AB; Wang, Y; Xu, Y; Zhao, Y	1

Other Studies

1 other study(ies) available for tricalcium phosphate and su 11248

Article	Year
Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment. Journal of controlled release : official journal of the Controlled Release Society, 2017, 01-10, Volume: 245 Topics: Animals; Antineoplastic Agents; Calcium Phosphates; Cancer Vaccines; Cell Line, Tumor; Cell Survival; Cytokines; Female; Immunotherapy, Active; Indoles; Melanoma; Membrane Proteins; Mice, Inbred C57BL; Micelles; Oligodeoxyribonucleotides; Peptide Fragments; Polymers; Proto-Oncogene Proteins c-akt; Pyrroles; STAT3 Transcription Factor; Sunitinib; Tumor Burden; Tumor Microenvironment	2017

Article

Year

Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment.

Journal of controlled release : official journal of the Controlled Release Society, 2017, 01-10, Volume: 245

Topics: Animals; Antineoplastic Agents; Calcium Phosphates; Cancer Vaccines; Cell Line, Tumor; Cell Survival; Cytokines; Female; Immunotherapy, Active; Indoles; Melanoma; Membrane Proteins; Mice, Inbred C57BL; Micelles; Oligodeoxyribonucleotides; Peptide Fragments; Polymers; Proto-Oncogene Proteins c-akt; Pyrroles; STAT3 Transcription Factor; Sunitinib; Tumor Burden; Tumor Microenvironment

2017